GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

9 Months Ended

Jul. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segment during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the nine months ended July 31, 2023:

	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2022	$	1,743	$	1,953	$	256	$	3,952
Foreign currency translation impact	11		1		5		17
Goodwill arising from acquisitions and adjustments	—		15		—		15
Goodwill as of July 31, 2023	$	1,754	$	1,969	$	261	$	3,984

Components of other intangible assets during the period

The component parts of other intangible assets as of October 31, 2022 and July 31, 2023 are shown in the table below:

 

	Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2022
Purchased technology	$	1,733	$	1,068	$	665
Trademark/Tradename	196		148		48
Customer relationships	180		105		75
Backlog	8		8		—
Third-party technology and licenses	32		9		23
Total amortizable intangible assets	2,149		1,338		811
In-Process R&D	10		—		10
Total	$	2,159	$	1,338	$	821
As of July 31, 2023
Purchased technology	$	1,470	$	1,078	$	392
Trademark/Tradename	196		159		37
Customer relationships	156		114		42
Third-party technology and licenses	33		12		21
Total amortizable intangible assets	1,855		1,363		492
In-Process R&D	10		—		10
Total	$	1,865	$	1,363	$	502

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:

Estimated future amortization expense:
(in millions)
Remainder of 2023	$	27
2024	$	100
2025	$	83
2026	$	53
2027	$	52
2028	$	45
Thereafter	$	132